Marcheix Bertrand, Lamarche Yoan, Perrault Pierre, Cartier Raymond, Bouchard Denis, Carrier Michel, Perrault Louis P, Demers Philippe
Department of Cardiovascular Surgery, Montreal Heart Institute, 5000 Belanger Street, Montreal, Quebec, Canada.
Eur J Cardiothorac Surg. 2007 Jun;31(6):1004-7. doi: 10.1016/j.ejcts.2007.02.036. Epub 2007 Apr 20.
Whatever the surgical technique used, false aneurysm formation is one of the long-term complications of repair of aortic coarctation. Conservative management is associated with a 100% rate of rupture. The conventional surgical approach is complex and associated with high morbidity and mortality rates. We report our experience of endovascular management of pseudo-aneurysms after previous surgical repair of congenital aortic coarctation.
Between October 2005 and 2006, stent-grafting of pseudo-aneurysms after previous surgical repair of congenital aortic coarctation was performed in four patients. Median age was 31.5 years (range: 24-38). Two patients had undergone two previous interventions. The last previous surgery consisted of graft interposition (N=2), subclavian flap aortoplasty (N=1) and aorto-aortic bypass (N=1). Median size of the pseudo-aneurysm was 31.5mm (range: 20-58). Mean time between the last surgery and endovascular treatment was 24 years (range: 3-32). One patient was treated emergently because of hemoptysis in relation with an aorto-bronchial fistula, the three other patients were treated electively. A transfemoral approach was used in all patients. The Zenith TX2 (Cook) thoracic stent-graft was used in all the patients, one patient underwent previous dilatation at the coarctation level. When present, the ostium of the left subclavian artery was always covered (N=3).
No major complication occurred during the procedure and no patient died during the follow-up. One patient presented a type II endoleak which spontaneously healed during the first month. Another patient with his left subclavian artery covered presented claudication of the left arm requiring a carotid-subclavian bypass. After a median follow-up of 7.5 months (range: 1-12.9), the patients were asymptomatic and CT scans demonstrated complete exclusion of all treated postcoarctation aneurysms without recoarctation and without any stent-graft-related complication.
The endovascular management of pseudo-aneurysms after previous surgical repair of congenital aortic coarctation is feasible. This approach was safe and effective. Long-term clinic and imaging follow-up is mandatory.
无论采用何种手术技术,假性动脉瘤形成都是主动脉缩窄修复术的长期并发症之一。保守治疗的破裂率为100%。传统手术方法复杂,且发病率和死亡率高。我们报告了先天性主动脉缩窄既往手术修复后假性动脉瘤的血管内治疗经验。
2005年10月至2006年期间,对4例先天性主动脉缩窄既往手术修复后的假性动脉瘤进行了支架植入术。中位年龄为31.5岁(范围:24 - 38岁)。2例患者曾接受过两次先前干预。上次手术包括移植血管置入(n = 2)、锁骨下皮瓣主动脉成形术(n = 1)和主动脉 - 主动脉旁路术(n = 1)。假性动脉瘤的中位大小为31.5mm(范围:20 - 58mm)。上次手术与血管内治疗之间的平均时间为24年(范围:3 - 32年)。1例患者因与主动脉 - 支气管瘘相关的咯血而紧急治疗,其他3例患者为择期治疗。所有患者均采用经股动脉途径。所有患者均使用了Zenith TX2(库克)胸段支架移植物,1例患者曾在缩窄部位进行过扩张。如有左锁骨下动脉开口,均予以覆盖(n = 3)。
手术过程中未发生重大并发症,随访期间无患者死亡。1例患者出现II型内漏,在第一个月内自发愈合。另1例左锁骨下动脉被覆盖的患者出现左臂间歇性跛行,需要进行颈动脉 - 锁骨下动脉旁路术。中位随访7.5个月(范围:1 - 12.9个月)后,患者无症状,CT扫描显示所有治疗的缩窄后动脉瘤完全被排除,无再缩窄且无任何与支架移植物相关的并发症。
先天性主动脉缩窄既往手术修复后假性动脉瘤的血管内治疗是可行的。该方法安全有效。必须进行长期临床和影像学随访。